273 related articles for article (PubMed ID: 22951237)
21. Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
Robinson DS; Gilmor ML; Yang Y; Moonsammy G; Azzaro AJ; Oren DA; Campbell BJ
Psychopharmacol Bull; 2007; 40(3):15-28. PubMed ID: 18007565
[TBL] [Abstract][Full Text] [Related]
22. Refractory depression treated with high doses of monoamine oxidase inhibitor.
Guze BH; Baxter LR; Rego J
J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
[TBL] [Abstract][Full Text] [Related]
23. Reversible monoamine oxidase-A inhibitors in resistant major depression.
Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
[TBL] [Abstract][Full Text] [Related]
24. Selegiline transdermal system: current awareness and promise.
Pae CU; Lim HK; Han C; Neena A; Lee C; Patkar AA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1153-63. PubMed ID: 17614182
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules.
Azzaro AJ; Ziemniak J; Kemper E; Campbell BJ; VanDenBerg C
J Clin Pharmacol; 2007 Oct; 47(10):1256-67. PubMed ID: 17715422
[TBL] [Abstract][Full Text] [Related]
26. Bipolar depression: treatment options.
Yatham LN; Kusumakar V; Parikh SV; Haslam DR; Matte R; Sharma V; Kennedy S
Can J Psychiatry; 1997 Aug; 42 Suppl 2():87S-91S. PubMed ID: 9288441
[TBL] [Abstract][Full Text] [Related]
27. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
Ghaemi SN
Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
[TBL] [Abstract][Full Text] [Related]
28. [High dosage tranylcypromine treatment of "therapy refractory" depressions].
Schmauss M
Nervenarzt; 1996 May; 67(5):390-3. PubMed ID: 9005348
[TBL] [Abstract][Full Text] [Related]
29. Upping the ante on antidepressants.
Malhi GS
Bipolar Disord; 2008 Dec; 10(8):975-8. PubMed ID: 19594513
[No Abstract] [Full Text] [Related]
30. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?
Marcason W
J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366
[No Abstract] [Full Text] [Related]
31. Transdermal selegiline.
Patkar AA; Pae CU; Zarzar M
Drugs Today (Barc); 2007 Jun; 43(6):361-77. PubMed ID: 17612708
[TBL] [Abstract][Full Text] [Related]
32. Transdermal selegiline: the new generation of monoamine oxidase inhibitors.
Patkar AA; Pae CU; Masand PS
CNS Spectr; 2006 May; 11(5):363-75. PubMed ID: 16641841
[TBL] [Abstract][Full Text] [Related]
33. Tyramine and new monoamine oxidase inhibitor drugs.
Simpson GM; de Leon J
Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
[TBL] [Abstract][Full Text] [Related]
34. [Rational use of antidepressants in general medicine].
Verbanck P; Cnockaert P
Rev Med Brux; 1996 Sep; 17(4):224-9. PubMed ID: 8927850
[TBL] [Abstract][Full Text] [Related]
35. Monoamine oxidase-inhibiting antidepressants. A clinical update.
Murphy DL; Sunderland T; Cohen RM
Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacotherapy of depression].
Kornacher J; Wolfersdorf M
MMW Fortschr Med; 2010 Mar; 152(9):46-9. PubMed ID: 20384097
[No Abstract] [Full Text] [Related]
37. Monoamine oxidase inhibitors revisited: what you should know.
Goldberg JF; Thase ME
J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
[No Abstract] [Full Text] [Related]
38. Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
Thase ME
J Clin Psychiatry; 2006 Apr; 67(4):671-2. PubMed ID: 16669733
[No Abstract] [Full Text] [Related]
39. The modern pharmacopoeia: a return to depressive realism?
Goldberg JF
Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
[No Abstract] [Full Text] [Related]
40. Major depressive disorder treatment guidelines in China.
Zhang M
J Clin Psychiatry; 2010; 71 Suppl E1():e06. PubMed ID: 20371033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]